Aquestive Therapeutics, Inc.AQ.STNASDAQ
Loading
EPS Growth Under PressureDecelerating
Percentile Rank21
3Y CAGR-49.9%
5Y CAGR-40.7%
Year-over-Year Change
Year-over-year earnings per share growth rate
3Y CAGR
-49.9%/yr
Annual compound
5Y CAGR
-40.7%/yr
Recent deceleration
Percentile
P21
Within normal range
vs 5Y Ago
0.1x
Contraction
Streak
2 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | 1.51% |
| 2024 | 5.21% |
| 2023 | 54.24% |
| 2022 | 12.00% |
| 2021 | 16.28% |
| 2020 | 20.70% |
| 2019 | 72.73% |
| 2018 | -26.01% |
| 2017 | -14.23% |
| 2016 | 37.57% |